Doxorubicin in experimental and clinical heart failure

44Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

Abstract

Doxorubicin-induced heart failure is a rare but serious illness due to the well-known treatment difficulties. Prevention strategies have not demonstrated the expected success and unfortunately, this specific type of heart failure does not respond to the usual medical therapy as other kinds of heart failure. Therefore, surgical procedures may be necessary in some patients. Cardiac transplantation is performed in most cases but it requires the cure of the neoplastic disease. This usually requires a recurrence-free interval of several years which is associated with a high attrition rate in these patients due to their cardiac disease. Therefore, other conservative and surgical treatment concepts were developed during the last years. This review presents the most common procedures and discusses their efficacy as well as their clinical applicability. © 2006 Elsevier B.V. All rights reserved.

Cite

CITATION STYLE

APA

Christiansen, S., & Autschbach, R. (2006, October). Doxorubicin in experimental and clinical heart failure. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1016/j.ejcts.2006.06.024

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free